Caricamento...
The efficacy and safety of riluzole for neurodegenerative movement disorders: a systematic review with meta-analysis
Neurodegenerative movement disorders mainly include Parkinson’s disease, atypical parkinsonisms, Huntington disease, and hereditary ataxia. Riluzole is the only drug approved by the US Food and Drug Administration for amyotrophic lateral sclerosis. The neuroprotective effects of riluzole have been o...
Salvato in:
| Pubblicato in: | Drug Deliv |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058579/ https://ncbi.nlm.nih.gov/pubmed/29226728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2017.1413446 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|